It has no approved indication, no standardized dosing, and no manufacturer-backed clinical data
Figures were created with UCSF Chimera and ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases
Throughout this period, the favorable safety profile remained consistent with no delayed-onset adverse effects or concerning laboratory changes emerging over time
Two separate vials win wherever the ratio has to be varied, wherever an observation needs attributing to one mechanism rather than the pair, or wherever one component is required without the other